These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17434299)

  • 1. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
    Glynne-Jones R; Meadows H; Wood W
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
    Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R
    J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?
    Glynne-Jones R; Sebag-Montefiore D
    J Clin Oncol; 2010 Oct; 28(29):e579-80; author reply e581-3. PubMed ID: 20733130
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.
    Allegra CJ; Yothers G; O'Connell MJ; Beart RW; Wozniak TF; Pitot HC; Shields AF; Landry JC; Ryan DP; Arora A; Evans LS; Bahary N; Soori G; Eakle JF; Robertson JM; Moore DF; Mullane MR; Marchello BT; Ward PJ; Sharif S; Roh MS; Wolmark N
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26374429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control.
    Glynne-Jones R; Counsell N; Quirke P; Mortensen N; Maraveyas A; Meadows HM; Ledermann J; Sebag-Montefiore D
    Ann Oncol; 2014 Jul; 25(7):1356-1362. PubMed ID: 24718885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].
    Suzuki S; Shigaki N; Yokoyama S; Yamashita H; Sugita H; Arima N
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1545-7. PubMed ID: 21918360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.
    Weiss C; Arnold D; Dellas K; Liersch T; Hipp M; Fietkau R; Sauer R; Hinke A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):472-8. PubMed ID: 20133081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
    Créhange G; Bosset JF; Maingon P
    Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiation for rectal cancer: is more better?
    Patel A; Puthillath A; Yang G; Fakih MG
    Oncology (Williston Park); 2008 Jun; 22(7):814-26; discussion 826, 828-31, 836. PubMed ID: 18619122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
    J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating oxaliplatin and capecitabine in adjuvant therapy of high-risk colorectal cancer.
    Maung K
    Clin Colorectal Cancer; 2003 Nov; 3(3):150-3. PubMed ID: 14706173
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent oxaliplatin, capecitabine, and radiation therapy in the neoadjuvant therapy of rectal adenocarcinoma: can we get the right dose first?
    Fakih MG
    Ann Oncol; 2006 Jun; 17(6):1029-30; author reply 1030-1. PubMed ID: 16384877
    [No Abstract]   [Full Text] [Related]  

  • 15. Rectal cancer: integrating oxaliplatin into chemoradiation studies.
    Ryan DP
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):38-41. PubMed ID: 11204662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.
    Sastre J; Custodio A; Sanchez JC; Ortega L; Rodriguez L; Puente J; Corona J; Alfonso R; de las Heras M; Dıaz-Rubio E
    Anticancer Drugs; 2011 Feb; 22(2):185-90. PubMed ID: 21218606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis.
    Sanghera P; Ho K; Muscroft T; Hartley A
    Br J Radiol; 2007 Aug; 80(956):e170-2. PubMed ID: 17762049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?
    Glynne-Jones R; Mawdsley S; Harrison M
    Acta Oncol; 2010 Apr; 49(3):278-86. PubMed ID: 20180626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma.
    Fakih MG; Bullarddunn K; Yang GY; Pendyala L; Toth K; Andrews C; Rustum YM; Ross ME; Levea C; Puthillath A; Park YM; Rajput A
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):650-7. PubMed ID: 18565686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
    Rödel C; Grabenbauer GG; Papadopoulos T; Hohenberger W; Schmoll HJ; Sauer R
    J Clin Oncol; 2003 Aug; 21(16):3098-104. PubMed ID: 12915600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.